| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.516 | 0.054 | 0.516 | Caspase 9 stimulant | |||
| 0.407 | 0.02 | 0.407 | Peroxidase inhibitor | 0.167 0.07 CID_154699784 | ||
| 0.431 | 0.075 | 0.431 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.269 0.258 CID_154699784 | ||
| 0.407 | 0.058 | 0.407 | GABA C receptor rho-3 antagonist | |||
| 0.369 | 0.027 | 0.369 | Transcription factor STAT inhibitor | |||
| 0.313 | 0.027 | 0.313 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.284 | 0.017 | 0.284 | Heat shock protein 90 alpha antagonist | |||
| 0.277 | 0.013 | 0.277 | 5-Lipoxygenase inhibitor | |||
| 0.298 | 0.054 | 0.298 | Tumour necrosis factor alpha release inhibitor | |||
| 0.252 | 0.013 | 0.252 | ATPase inhibitor | |||
| 0.247 | 0.017 | 0.247 | Alkylator | 0.145 0.049 CID_154699784 | ||
| 0.29 | 0.061 | 0.29 | DNA damaging | |||
| 0.246 | 0.022 | 0.246 | Heat shock protein 90 antagonist | |||
| 0.239 | 0.018 | 0.239 | DNA intercalator | 0.166 0.036 CID_154699784 | ||
| 0.238 | 0.026 | 0.238 | Topoisomerase II inhibitor | 0.128 0.061 CID_154699784 | ||
| 0.348 | 0.14 | 0.348 | Apoptosis agonist | |||
| 0.249 | 0.043 | 0.249 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.283 | 0.08 | 0.283 | Lipoxygenase inhibitor | |||
| 0.332 | 0.131 | 0.332 | 5 Hydroxytryptamine release inhibitor | |||
| 0.212 | 0.022 | 0.212 | Cystathionine beta-synthase inhibitor | 0.095 0.082 CID_154699784 | ||
| 0.196 | 0.015 | 0.196 | Topoisomerase II alpha inhibitor | 0.116 0.031 CID_154699784 | ||
| 0.202 | 0.026 | 0.202 | Topoisomerase I inhibitor | 0.111 0.061 CID_154699784 | ||
| 0.245 | 0.084 | 0.245 | Aldehyde oxidase inhibitor | |||
| 0.178 | 0.019 | 0.178 | Mediator release inhibitor | |||
| 0.244 | 0.088 | 0.244 | Transcription factor STAT3 inhibitor | |||
| 0.188 | 0.037 | 0.188 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.178 | 0.028 | 0.178 | MAP3K9 inhibitor | |||
| 0.22 | 0.075 | 0.22 | MAP kinase kinase 3 inhibitor | |||
| 0.161 | 0.019 | 0.161 | Telomerase inhibitor | |||
| 0.238 | 0.101 | 0.238 | Immunostimulant | 0.165 0.142 CID_154699784 | ||
| 0.272 | 0.14 | 0.366 | Histamine release inhibitor | 0.366 0.092 CID_154699784 | CID_154699784 | |
| 0.243 | 0.113 | 0.243 | 12-Lipoxygenase inhibitor | |||
| 0.15 | 0.02 | 0.185 | Triose-phosphate isomerase inhibitor | 0.185 0.013 CID_154699784 | CID_154699784 | |
| 0.206 | 0.078 | 0.206 | Pyruvate kinase inhibitor | |||
| 0.215 | 0.095 | 0.215 | Aryl hydrocarbon receptor agonist | |||
| 0.142 | 0.028 | 0.142 | Sphingomyelinase inhibitor | |||
| 0.143 | 0.034 | 0.143 | GABA C receptor antagonist | |||
| 0.168 | 0.06 | 0.168 | Hexokinase inhibitor | |||
| 0.185 | 0.084 | 0.185 | Non-steroidal antiinflammatory agent | |||
| 0.146 | 0.054 | 0.146 | Ca2+-transporting ATPase inhibitor | |||
| 0.111 | 0.02 | 0.111 | GABA aminotransferase inhibitor | |||
| 0.129 | 0.038 | 0.129 | UDP-glucose 4-epimerase inhibitor | |||
| 0.153 | 0.063 | 0.153 | MAP kinase 3 inhibitor | |||
| 0.095 | 0.01 | 0.095 | Histone deacetylase 5 inhibitor | |||
| 0.093 | 0.008 | 0.093 | Histone deacetylase class II inhibitor | |||
| 0.217 | 0.133 | 0.217 | Insulysin inhibitor | |||
| 0.168 | 0.083 | 0.168 | Succinate dehydrogenase inhibitor | 0.151 0.11 CID_154699784 | ||
| 0.108 | 0.026 | 0.108 | Glutamate decarboxylase inhibitor | |||
| 0.142 | 0.06 | 0.142 | Acetylcholinesterase inhibitor | |||
| 0.221 | 0.141 | 0.221 | Caspase 3 stimulant | |||
| 0.15 | 0.073 | 0.15 | GABA C receptor rho-2 antagonist | |||
| 0.101 | 0.025 | 0.101 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.132 | 0.058 | 0.132 | Adenylate cyclase inhibitor | |||
| 0.212 | 0.138 | 0.212 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.107 | 0.034 | 0.107 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_154699784 | ||
| 0.133 | 0.06 | 0.133 | CC chemokine 6 receptor antagonist | |||
| 0.124 | 0.052 | 0.124 | Transcription factor STAT6 inhibitor | |||
| 0.117 | 0.046 | 0.117 | Carbonic anhydrase III inhibitor | 0.085 0.082 CID_154699784 | ||
| 0.081 | 0.011 | 0.081 | Histone deacetylase 2 inhibitor | |||
| 0.113 | 0.047 | 0.113 | Creatine kinase inhibitor | 0.098 0.062 CID_154699784 | ||
| 0.121 | 0.056 | 0.121 | Photosensitizer | |||
| 0.158 | 0.094 | 0.158 | Lipocortins synthesis antagonist | |||
| 0.07 | 0.009 | 0.07 | Histone deacetylase class IIb inhibitor | |||
| 0.189 | 0.129 | 0.336 | Superoxide dismutase inhibitor | 0.336 0.04 CID_154699784 | CID_154699784 | |
| 0.068 | 0.009 | 0.068 | Histone deacetylase 6 inhibitor | |||
| 0.068 | 0.011 | 0.068 | Histone deacetylase class IIa inhibitor | |||
| 0.192 | 0.136 | 0.192 | DNA synthesis inhibitor | |||
| 0.154 | 0.098 | 0.181 | Phospholipase C inhibitor | 0.181 0.06 CID_154699784 | CID_154699784 | |
| 0.111 | 0.056 | 0.111 | GABA C receptor agonist | |||
| 0.063 | 0.01 | 0.063 | Histone deacetylase 1 inhibitor | |||
| 0.062 | 0.01 | 0.062 | Histone deacetylase class IV inhibitor | |||
| 0.062 | 0.01 | 0.062 | Histone deacetylase 11 inhibitor | |||
| 0.078 | 0.026 | 0.078 | Aminopeptidase microsomal inhibitor | |||
| 0.106 | 0.054 | 0.106 | Estrogen receptor beta antagonist | |||
| 0.064 | 0.015 | 0.064 | Thymidylate synthase inhibitor | |||
| 0.082 | 0.034 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.121 | 0.077 | 0.121 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.054 | 0.01 | 0.054 | Histone deacetylase 10 inhibitor | |||
| 0.065 | 0.022 | 0.065 | Dihydroorotate oxidase inhibitor | |||
| 0.084 | 0.043 | 0.084 | Estrogen receptor alpha antagonist | |||
| 0.081 | 0.042 | 0.229 | CDC25A inhibitor | 0.229 0.005 CID_154699784 | CID_154699784 | |
| 0.067 | 0.029 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.124 | 0.089 | 0.124 | Protein kinase stimulant | |||
| 0.231 | 0.196 | 0.399 | Antibacterial | 0.399 0.078 CID_154699784 | CID_154699784 | |
| 0.114 | 0.08 | 0.114 | MAP kinase kinase inhibitor | |||
| 0.147 | 0.114 | 0.147 | Death-associated protein kinase 2 inhibitor | |||
| 0.1 | 0.067 | 0.1 | Adenylate kinase inhibitor | 0.092 0.082 CID_154699784 | ||
| 0.107 | 0.074 | 0.107 | Interleukin 1b antagonist | |||
| 0.047 | 0.014 | 0.047 | Histone deacetylase 4 inhibitor | |||
| 0.1 | 0.067 | 0.1 | Urease inhibitor | |||
| 0.146 | 0.114 | 0.146 | Catenin beta inhibitor | |||
| 0.055 | 0.023 | 0.055 | Collagenase inhibitor | |||
| 0.131 | 0.1 | 0.135 | Adenylate cyclase stimulant | 0.135 0.091 CID_154699784 | CID_154699784 | |
| 0.102 | 0.072 | 0.102 | DOPA decarboxylase inhibitor | |||
| 0.054 | 0.024 | 0.054 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.056 | 0.027 | 0.056 | Aminopeptidase N inhibitor | |||
| 0.097 | 0.067 | 0.115 | Aminopeptidase B inhibitor | 0.115 0.055 CID_154699784 | CID_154699784 | |
| 0.154 | 0.125 | 0.154 | Focal adhesion kinase 2 inhibitor | |||
| 0.028 | 0.004 | 0.028 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.133 | 0.108 | 0.133 | Melanin inhibitor | |||
| 0.039 | 0.016 | 0.039 | ADAM10 endopeptidase inhibitor | |||
| 0.093 | 0.072 | 0.093 | GABA C receptor rho-1 antagonist | |||
| 0.034 | 0.013 | 0.034 | Histone deacetylase 3 inhibitor | |||
| 0.082 | 0.061 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.051 | 0.032 | 0.051 | CD45 antagonist | |||
| 0.105 | 0.086 | 0.105 | Estrogen antagonist | |||
| 0.062 | 0.044 | 0.062 | NMDA receptor glycine site agonist | |||
| 0.064 | 0.046 | 0.064 | Histone deacetylase inhibitor | |||
| 0.189 | 0.174 | 0.189 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.041 | 0.027 | 0.041 | Acid-sensing ion channel blocker | |||
| 0.061 | 0.048 | 0.061 | CDC25B inhibitor | |||
| 0.085 | 0.074 | 0.085 | Glutamate release inhibitor | |||
| 0.168 | 0.156 | 0.234 | RNA-directed DNA polymerase inhibitor | 0.234 0.061 CID_154699784 | CID_154699784 | |
| 0.135 | 0.123 | 0.135 | DNA methyltransferase I inhibitor | |||
| 0.052 | 0.043 | 0.052 | Alcohol oxidase inhibitor | |||
| 0.081 | 0.073 | 0.081 | NADH dehydrogenase inhibitor | |||
| 0.102 | 0.095 | 0.102 | Aldehyde dehydrogenase inhibitor | |||
| 0.107 | 0.102 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.052 | 0.049 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.088 | 0.085 | 0.088 | Ferrochelatase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.028 | 0.036 | 0.059 | Purinergic P2Y2 antagonist | 0.059 0.008 CID_154699784 | CID_154699784 | |
| 0.081 | 0.095 | 0.105 | Anabolic | 0.105 0.055 CID_154699784 | CID_154699784 | |
| 0.076 | 0.098 | 0.113 | Protein kinase C zeta inhibitor | 0.113 0.038 CID_154699784 | CID_154699784 | |
| 0.036 | 0.083 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.029 CID_154699784 | CID_154699784 | |
| 0.043 | 0.096 | 0.092 | Catalase inhibitor | 0.092 0.041 CID_154699784 | CID_154699784 | |
| 0.025 | 0.08 | 0.055 | Carbonic anhydrase VB inhibitor | 0.055 0.04 CID_154699784 | CID_154699784 | |
| 0.025 | 0.087 | 0.046 | Mannosidase inhibitor | 0.046 0.03 CID_154699784 | CID_154699784 | |
| 0.037 | 0.104 | 0.11 | HIV-1 integrase (3'-Processing) inhibitor | 0.11 0.022 CID_154699784 | CID_154699784 | |
| 0.053 | 0.12 | 0.072 | Glycine receptor antagonist | 0.072 0.07 CID_154699784 | CID_154699784 | |
| 0.079 | 0.151 | 0.111 | Acetylcholine release stimulant | 0.111 0.065 CID_154699784 | CID_154699784 | |
| 0.034 | 0.108 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.057 CID_154699784 | CID_154699784 | |
| 0.029 | 0.105 | 0.109 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.019 CID_154699784 | CID_154699784 | |
| 0.009 | 0.099 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_154699784 | CID_154699784 | |
| 0.012 | 0.109 | 0.068 | NMDA 2D receptor antagonist | 0.068 0.005 CID_154699784 | CID_154699784 | |
| 0.037 | 0.146 | 0.065 | Phospholipase D inhibitor | 0.065 0.064 CID_154699784 | CID_154699784 | |
| 0.027 | 0.172 | 0.049 | Heparanase inhibitor | 0.049 0.047 CID_154699784 | CID_154699784 | |
| 0.072 | 0.23 | 0.14 | Cell wall synthesis inhibitor | 0.14 0.075 CID_154699784 | CID_154699784 | |
| 0.07 | 0.339 | 0.213 | Antioxidant | 0.213 0.105 CID_154699784 | CID_154699784 | |
| 0.026 | 0.375 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 CID_154699784 | CID_154699784 | |
| 0.03 | 0.447 | 0.388 | Dual specificity phosphatase inhibitor | 0.388 0.015 CID_154699784 | CID_154699784 | |
| 0.022 | 0.442 | 0.261 | Diuretic | 0.261 0.029 CID_154699784 | CID_154699784 | |
| 0.018 | 0.475 | 0.195 | Protein-tyrosine phosphatase inhibitor | 0.195 0.049 CID_154699784 | CID_154699784 | |
| 0.016 | 0.594 | 0.351 | Dual specificity phosphatase 3 inhibitor | 0.351 0.02 CID_154699784 | CID_154699784 | |
| 0.005 | 0.592 | 0.083 | Selectin antagonist | 0.083 0.035 CID_154699784 | CID_154699784 | |
| 0.017 | 0.614 | 0.309 | Angiogenesis stimulant | 0.309 0.046 CID_154699784 | CID_154699784 | |
| 0.006 | 0.894 | 0.259 | Cholecystokinin B agonist | 0.259 0.004 CID_154699784 | CID_154699784 | |
| 0.002 | 0.917 | 0.117 | Cholecystokinin A agonist | 0.117 0.004 CID_154699784 | CID_154699784 | |
| 0.002 | 0.922 | 0.031 | Cholecystokinin A antagonist | 0.031 0.03 CID_154699784 | CID_154699784 | |
| 0.002 | 0.928 | 0.119 | Cholecystokinin agonist | 0.119 0.004 CID_154699784 | CID_154699784 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |